Myelodysplastic Syndrome | Dr. Tony Talebi discusses "Treatment of Myelodysplastic Syndrome?"

Dr. Tony Talebi discusses "What is the Treatment of Myelodysplastic Syndrome?" with Dr. Byrnes. For further discussion visit http://www.HemOnc101.com What is the Treatment of Myelodysplastic Syndrome: The myelodysplastic syndromes (MDS) comprise a heterogeneous group of cancerous stem cell disorders characterized by dysplastic (abnormal) and ineffective blood cell production and a variable risk of transformation to acute leukemia. These disorders may occur de novo or arise years after exposure to potentially mutagenic therapy (eg, radiation exposure, chemotherapy). The risk of developing MDS increases with age. Signs and symptoms at presentation of MDS are non-specific. Many patients are asymptomatic, with the diagnosis established upon routine laboratory screening. Others present with symptoms resulting from a previously unrecognized anemia, including fatigue, weakness, exercise intolerance, angina, dizziness, cognitive impairment, or an altered sense of well being.